-
1
-
-
37549026844
-
Replicating and non-replicating viral vectors for vaccine development
-
Robert-Guroff M. 2007. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol. 18:546-556. http://dx.doi.org/10.1016/j.copbio.2007.10.010.
-
(2007)
Curr. Opin. Biotechnol.
, vol.18
, pp. 546-556
-
-
Robert-Guroff, M.1
-
2
-
-
84880353735
-
Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus
-
Manrique J, Piatak M, Lauer W, Johnson W, Mansfield K, Lifson J, Desrosiers R. 2013. Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus. J. Virol. 87:7246-7254. http://dx.doi.org/10.1128/JVI.00798-13.
-
(2013)
J. Virol.
, vol.87
, pp. 7246-7254
-
-
Manrique, J.1
Piatak, M.2
Lauer, W.3
Johnson, W.4
Mansfield, K.5
Lifson, J.6
Desrosiers, R.7
-
3
-
-
2442611810
-
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
-
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J. 2004. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 172:6290-6297.
-
(2004)
J. Immunol.
, vol.172
, pp. 6290-6297
-
-
Barouch, D.H.1
Pau, M.G.2
Custers, J.H.3
Koudstaal, W.4
Kostense, S.5
Havenga, M.J.6
Truitt, D.M.7
Sumida, S.M.8
Kishko, M.G.9
Arthur, J.C.10
Korioth-Schmitz, B.11
Newberg, M.H.12
Gorgone, D.A.13
Lifton, M.A.14
Panicali, D.L.15
Nabel, G.J.16
Letvin, N.L.17
Goudsmit, J.18
-
4
-
-
0038664390
-
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene
-
Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW. 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77:6305-6313. http://dx.doi.org/10.1128/JVI.77.11.6305-6313.2003.
-
(2003)
J. Virol.
, vol.77
, pp. 6305-6313
-
-
Casimiro, D.R.1
Chen, L.2
Fu, T.M.3
Evans, R.K.4
Caulfield, M.J.5
Davies, M.E.6
Tang, A.7
Chen, M.8
Huang, L.9
Harris, V.10
Freed, D.C.11
Wilson, K.A.12
Dubey, S.13
Zhu, D.M.14
Nawrocki, D.15
Mach, H.16
Troutman, R.17
Isopi, L.18
Williams, D.19
Hurni, W.20
Xu, Z.21
Smith, J.G.22
Wang, S.23
Liu, X.24
Guan, L.25
Long, R.26
Trigona, W.27
Heidecker, G.J.28
Perry, H.C.29
Persaud, N.30
Toner, T.J.31
Su, Q.32
Liang, X.33
Youil, R.34
Chastain, M.35
Bett, A.J.36
Volkin, D.B.37
Emini, E.A.38
Shiver, J.W.39
more..
-
5
-
-
34547763195
-
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
-
Santra S, Sun Y, Parvani JG, Philippon V, Wyand MS, Manson K, Gomez-Yafal A, Mazzara G, Panicali D, Markham PD, Montefiori DC, Letvin NL. 2007. Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors. J. Virol. 81:8563-8570. http://dx.doi.org/10.1128/JVI.00744-07.
-
(2007)
J. Virol.
, vol.81
, pp. 8563-8570
-
-
Santra, S.1
Sun, Y.2
Parvani, J.G.3
Philippon, V.4
Wyand, M.S.5
Manson, K.6
Gomez-Yafal, A.7
Mazzara, G.8
Panicali, D.9
Markham, P.D.10
Montefiori, D.C.11
Letvin, N.L.12
-
6
-
-
0032897970
-
Attenuated vesicular stomatitis viruses as vaccine vectors
-
Roberts A, Buonocore L, Price R, Forman J, Rose JK. 1999. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:3723-3732.
-
(1999)
J. Virol.
, vol.73
, pp. 3723-3732
-
-
Roberts, A.1
Buonocore, L.2
Price, R.3
Forman, J.4
Rose, J.K.5
-
7
-
-
0036184412
-
High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses
-
Haglund K, Leiner I, Kerksiek K, Buonocore L, Pamer E, Rose JK. 2002. High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. J. Virol. 76:2730-2738. http://dx.doi.org/10.1128/JVI.76.6.2730-2738.2002.
-
(2002)
J. Virol.
, vol.76
, pp. 2730-2738
-
-
Haglund, K.1
Leiner, I.2
Kerksiek, K.3
Buonocore, L.4
Pamer, E.5
Rose, J.K.6
-
8
-
-
80054741833
-
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections
-
Geisbert TW, Feldmann H. 2011. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 204(Suppl 3):S1075-S1081. http://dx.doi.org/10.1093/infdis/jir349.
-
(2011)
J. Infect. Dis.
, vol.204
, Issue.SUPPL. 3
-
-
Geisbert, T.W.1
Feldmann, H.2
-
9
-
-
17944369239
-
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
-
Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK. 2001. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549. http://dx.doi.org/10.1016/S0092-8674(01)00482-2.
-
(2001)
Cell
, vol.106
, pp. 539-549
-
-
Rose, N.F.1
Marx, P.A.2
Luckay, A.3
Nixon, D.F.4
Moretto, W.J.5
Donahoe, S.M.6
Montefiori, D.7
Roberts, A.8
Buonocore, L.9
Rose, J.K.10
-
10
-
-
77950826934
-
Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge
-
Schwartz JA, Buonocore L, Suguitan AL, Jr, Silaghi A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK. 2010. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J. Virol. 84:4611-4618. http://dx.doi.org/10.1128/JVI.02637-09.
-
(2010)
J. Virol.
, vol.84
, pp. 4611-4618
-
-
Schwartz, J.A.1
Buonocore, L.2
Suguitan Jr., A.L.3
Silaghi, A.4
Kobasa, D.5
Kobinger, G.6
Feldmann, H.7
Subbarao, K.8
Rose, J.K.9
-
11
-
-
0001424129
-
Rhabdoviridae: the viruses and their replication
-
Fields BN, Knipe DM, Howley PM (ed), Philadelphia, PA.
-
Wagner RR, Rose JK. 1996. Rhabdoviridae: the viruses and their replication, p 1121-1136. In Fields BN, Knipe DM, Howley PM (ed), Fields virology. Lippincott-Raven, Philadelphia, PA.
-
(1996)
Fields virology. Lippincott-Raven
, pp. 1121-1136
-
-
Wagner, R.R.1
Rose, J.K.2
-
12
-
-
0034527958
-
VSV-NJ on Ossabaw Island, Georgia. The truth is out there
-
Stallknecht DE. 2000. VSV-NJ on Ossabaw Island, Georgia. The truth is out there. Ann. N. Y. Acad. Sci. 916:431-436. http://dx.doi.org/10.1111/j.1749-6632.2000.tb05322.x.
-
(2000)
Ann. N. Y. Acad. Sci.
, vol.916
, pp. 431-436
-
-
Stallknecht, D.E.1
-
13
-
-
2342531185
-
Vesicular stomatitis virus: re-inventing the bullet
-
Lichty BD, Power AT, Stojdl DF, Bell JC. 2004. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol. Med. 10:210-216. http://dx.doi.org/10.1016/j.molmed.2004.03.003.
-
(2004)
Trends Mol. Med.
, vol.10
, pp. 210-216
-
-
Lichty, B.D.1
Power, A.T.2
Stojdl, D.F.3
Bell, J.C.4
-
14
-
-
0034090316
-
Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope
-
Haglund K, Forman J, Krausslich HG, Rose JK. 2000. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268: 112-121. http://dx.doi.org/10.1006/viro.1999.0120.
-
(2000)
Virology
, vol.268
, pp. 112-121
-
-
Haglund, K.1
Forman, J.2
Krausslich, H.G.3
Rose, J.K.4
-
15
-
-
84865139750
-
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
-
Muik A, Dold C, Geiss Y, Volk A, Werbizki M, Dietrich U, von Laer D. 2012. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy. J. Mol. Med. 90:959-970. http://dx.doi.org/10.1007/s00109-012-0863-6.
-
(2012)
J. Mol. Med.
, vol.90
, pp. 959-970
-
-
Muik, A.1
Dold, C.2
Geiss, Y.3
Volk, A.4
Werbizki, M.5
Dietrich, U.6
von Laer, D.7
-
16
-
-
0034467097
-
Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1
-
Rose NF, Roberts A, Buonocore L, Rose JK. 2000. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J. Virol. 74:10903-10910. http://dx.doi.org/10.1128/JVI.74.23.10903-10910.2000.
-
(2000)
J. Virol.
, vol.74
, pp. 10903-10910
-
-
Rose, N.F.1
Roberts, A.2
Buonocore, L.3
Rose, J.K.4
-
17
-
-
33847105395
-
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in nonhuman primates
-
Johnson JE, Nasar F, Coleman JW, Price RE, Javadian A, Draper K, Lee M, Reilly PA, Clarke DK, Hendry RM, Udem SA. 2007. Neurovirulence properties of recombinant vesicular stomatitis virus vectors in nonhuman primates. Virology 360:36-49. http://dx.doi.org/10.1016/j.virol.2006.10.026.
-
(2007)
Virology
, vol.360
, pp. 36-49
-
-
Johnson, J.E.1
Nasar, F.2
Coleman, J.W.3
Price, R.E.4
Javadian, A.5
Draper, K.6
Lee, M.7
Reilly, P.A.8
Clarke, D.K.9
Hendry, R.M.10
Udem, S.A.11
-
18
-
-
37349122809
-
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice
-
Cooper D, Wright KJ, Calderon PC, Guo M, Nasar F, Johnson JE, Coleman JW, Lee M, Kotash C, Yurgelonis I, Natuk RJ, Hendry RM, Udem SA, Clarke DK. 2008. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice. J. Virol. 82:207-219. http://dx.doi.org/10.1128/JVI.01515-07.
-
(2008)
J. Virol.
, vol.82
, pp. 207-219
-
-
Cooper, D.1
Wright, K.J.2
Calderon, P.C.3
Guo, M.4
Nasar, F.5
Johnson, J.E.6
Coleman, J.W.7
Lee, M.8
Kotash, C.9
Yurgelonis, I.10
Natuk, R.J.11
Hendry, R.M.12
Udem, S.A.13
Clarke, D.K.14
-
19
-
-
33751099557
-
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
-
Clarke DK, Cooper D, Egan MA, Hendry RM, Parks CL, Udem SA. 2006. Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector. Springer Semin. Immunopathol. 28:239-253. http://dx.doi.org/10.1007/s00281-006-0042-3.
-
(2006)
Springer Semin. Immunopathol.
, vol.28
, pp. 239-253
-
-
Clarke, D.K.1
Cooper, D.2
Egan, M.A.3
Hendry, R.M.4
Parks, C.L.5
Udem, S.A.6
-
20
-
-
9244254780
-
Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins
-
Miletic H, Fischer YH, Neumann H, Hans V, Stenzel W, Giroglou T, Hermann M, Deckert M, Von Laer D. 2004. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum. Gene Ther. 15:1091-1100. http://dx.doi.org/10.1089/hum.2004.15.1091.
-
(2004)
Hum. Gene Ther.
, vol.15
, pp. 1091-1100
-
-
Miletic, H.1
Fischer, Y.H.2
Neumann, H.3
Hans, V.4
Stenzel, W.5
Giroglou, T.6
Hermann, M.7
Deckert, M.8
Von Laer, D.9
-
21
-
-
0035158867
-
Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference
-
Beyer WR, Miletic H, Ostertag W, von Laer D. 2001. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J. Virol. 75:1061-1064. http://dx.doi.org/10.1128/JVI.75.2.1061-1064.2001.
-
(2001)
J. Virol.
, vol.75
, pp. 1061-1064
-
-
Beyer, W.R.1
Miletic, H.2
Ostertag, W.3
von Laer, D.4
-
22
-
-
79956119782
-
Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism
-
Muik A, Kneiske I, Werbizki M, Wilflingseder D, Giroglou T, Ebert O, Kraft A, Dietrich U, Zimmer G, Momma S, von Laer D. 2011. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J. Virol. 85:5679-5684. http://dx.doi.org/10.1128/JVI.02511-10.
-
(2011)
J. Virol.
, vol.85
, pp. 5679-5684
-
-
Muik, A.1
Kneiske, I.2
Werbizki, M.3
Wilflingseder, D.4
Giroglou, T.5
Ebert, O.6
Kraft, A.7
Dietrich, U.8
Zimmer, G.9
Momma, S.10
von Laer, D.11
-
23
-
-
0028798803
-
Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus
-
Moskophidis D, Battegay M, van den Broek M, Laine E, Hoffmann-Rohrer U, Zinkernagel RM. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381-391. http://dx.doi.org/10.1099/0022-1317-76-2-381.
-
(1995)
J. Gen. Virol.
, vol.76
, pp. 381-391
-
-
Moskophidis, D.1
Battegay, M.2
van den Broek, M.3
Laine, E.4
Hoffmann-Rohrer, U.5
Zinkernagel, R.M.6
-
24
-
-
0037083612
-
Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses
-
Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-1532.
-
(2002)
J. Immunol.
, vol.168
, pp. 1528-1532
-
-
Foulds, K.E.1
Zenewicz, L.A.2
Shedlock, D.J.3
Jiang, J.4
Troy, A.E.5
Shen, H.6
-
25
-
-
0032804396
-
Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway
-
Boritz E, Gerlach J, Johnson JE, Rose JK. 1999. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73:6937-6945.
-
(1999)
J. Virol.
, vol.73
, pp. 6937-6945
-
-
Boritz, E.1
Gerlach, J.2
Johnson, J.E.3
Rose, J.K.4
-
26
-
-
0029912980
-
The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus
-
Schnell MJ, Buonocore L, Whitt MA, Rose JK. 1996. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:2318-2323.
-
(1996)
J. Virol.
, vol.70
, pp. 2318-2323
-
-
Schnell, M.J.1
Buonocore, L.2
Whitt, M.A.3
Rose, J.K.4
-
27
-
-
2342637176
-
Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer
-
Ebert O, Shinozaki K, Kournioti C, Park MS, Garcia-Sastre A, Woo SL. 2004. Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. Cancer Res. 64:3265-3270. http://dx.doi.org/10.1158/0008-5472.CAN-03-3753.
-
(2004)
Cancer Res.
, vol.64
, pp. 3265-3270
-
-
Ebert, O.1
Shinozaki, K.2
Kournioti, C.3
Park, M.S.4
Garcia-Sastre, A.5
Woo, S.L.6
-
28
-
-
0034633740
-
Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production
-
Schiedner G, Hertel S, Kochanek S. 2000. Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 11:2105-2116. http://dx.doi.org/10.1089/104303400750001417.
-
(2000)
Hum. Gene Ther.
, vol.11
, pp. 2105-2116
-
-
Schiedner, G.1
Hertel, S.2
Kochanek, S.3
-
29
-
-
0036019186
-
A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations
-
Kreppel F, Biermann V, Kochanek S, Schiedner G. 2002. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther. 13:1151-1156. http://dx.doi.org/10.1089/10430340232013 8934.
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 1151-1156
-
-
Kreppel, F.1
Biermann, V.2
Kochanek, S.3
Schiedner, G.4
-
30
-
-
84866756978
-
Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits
-
Mruk DD, Cheng CY. 2011. Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits. Spermatogenesis 1:121-122. http://dx.doi.org/10.4161/spmg.1.2.16606.
-
(2011)
Spermatogenesis
, vol.1
, pp. 121-122
-
-
Mruk, D.D.1
Cheng, C.Y.2
-
31
-
-
34250971354
-
50% end-point calculation
-
Kaerber G. 1931. 50% end-point calculation. Arch. Exp. Pathol. Pharmakol. 162:480-483. http://dx.doi.org/10.1007/BF01863914.
-
(1931)
Arch. Exp. Pathol. Pharmakol.
, vol.162
, pp. 480-483
-
-
Kaerber, G.1
-
32
-
-
55249087037
-
Resistance of mature T cells to oncogene transformation
-
Newrzela S, Cornils K, Li Z, Baum C, Brugman MH, Hartmann M, Meyer J, Hartmann S, Hansmann ML, Fehse B, von Laer D. 2008. Resistance of mature T cells to oncogene transformation. Blood 112: 2278-2286. http://dx.doi.org/10.1182/blood-2007-12-128751.
-
(2008)
Blood
, vol.112
, pp. 2278-2286
-
-
Newrzela, S.1
Cornils, K.2
Li, Z.3
Baum, C.4
Brugman, M.H.5
Hartmann, M.6
Meyer, J.7
Hartmann, S.8
Hansmann, M.L.9
Fehse, B.10
von Laer, D.11
-
33
-
-
35448959374
-
Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus
-
Eschli B, Zellweger RM, Wepf A, Lang KS, Quirin K, Weber J, Zinkernagel RM, Hengartner H. 2007. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J. Virol. 81: 11650-11657. http://dx.doi.org/10.1128/JVI.00955-07.
-
(2007)
J. Virol.
, vol.81
, pp. 11650-11657
-
-
Eschli, B.1
Zellweger, R.M.2
Wepf, A.3
Lang, K.S.4
Quirin, K.5
Weber, J.6
Zinkernagel, R.M.7
Hengartner, H.8
-
34
-
-
0035862330
-
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
-
Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193:169-180. http://dx.doi.org/10.1084/jem.193.2.169.
-
(2001)
J. Exp. Med.
, vol.193
, pp. 169-180
-
-
Altfeld, M.1
Rosenberg, E.S.2
Shankarappa, R.3
Mukherjee, J.S.4
Hecht, F.M.5
Eldridge, R.L.6
Addo, M.M.7
Poon, S.H.8
Phillips, M.N.9
Robbins, G.K.10
Sax, P.E.11
Boswell, S.12
Kahn, J.O.13
Brander, C.14
Goulder, P.J.15
Levy, J.A.16
Mullins, J.I.17
Walker, B.D.18
-
35
-
-
0036311547
-
Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology
-
Jayakar HR, Whitt MA. 2002. Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J. Virol. 76:8011-8018. http://dx.doi.org/10.1128/JVI.76.16.8011-8018.2002.
-
(2002)
J. Virol.
, vol.76
, pp. 8011-8018
-
-
Jayakar, H.R.1
Whitt, M.A.2
-
36
-
-
80555135981
-
Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains
-
Diallo JS, Vaha-Koskela M, Le Boeuf F, Bell J. 2012. Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Methods Mol. Biol. 797:127-140. http://dx.doi.org/10.1007/978-1-61779-340-0_10.
-
(2012)
Methods Mol. Biol.
, vol.797
, pp. 127-140
-
-
Diallo, J.S.1
Vaha-Koskela, M.2
Le Boeuf, F.3
Bell, J.4
-
37
-
-
33344479421
-
Antiviral antibody responses: the two extremes of a wide spectrum
-
Hangartner L, Zinkernagel RM, Hengartner H. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6:231-243. http://dx.doi.org/10.1038/nri1783.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 231-243
-
-
Hangartner, L.1
Zinkernagel, R.M.2
Hengartner, H.3
-
38
-
-
37549043879
-
Fully detargeted polyethylene glycolcoated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies
-
Wortmann A, Vohringer S, Engler T, Corjon S, Schirmbeck R, Reimann J, Kochanek S, Kreppel F. 2008. Fully detargeted polyethylene glycolcoated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies. Mol. Ther. 16:154-162. http://dx.doi.org/10.1038/sj.mt.6300306.
-
(2008)
Mol. Ther.
, vol.16
, pp. 154-162
-
-
Wortmann, A.1
Vohringer, S.2
Engler, T.3
Corjon, S.4
Schirmbeck, R.5
Reimann, J.6
Kochanek, S.7
Kreppel, F.8
-
39
-
-
56149115867
-
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice
-
Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. 2008. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One 3:e3548. http://dx.doi.org/10.1371/journal.pone.0003548.
-
(2008)
PLoS One
, vol.3
-
-
Croyle, M.A.1
Patel, A.2
Tran, K.N.3
Gray, M.4
Zhang, Y.5
Strong, J.E.6
Feldmann, H.7
Kobinger, G.P.8
-
40
-
-
84859181562
-
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates
-
Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. 2012. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl. Trop. Dis. 6:e1567. http://dx.doi.org/10.1371/journal.pntd.0001567.
-
(2012)
PLoS Negl. Trop. Dis.
, vol.6
-
-
Mire, C.E.1
Miller, A.D.2
Carville, A.3
Westmoreland, S.V.4
Geisbert, J.B.5
Mansfield, K.G.6
Feldmann, H.7
Hensley, L.E.8
Geisbert, T.W.9
-
41
-
-
77950957568
-
Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates
-
Jenks N, Myers R, Greiner SM, Thompson J, Mader EK, Greenslade A, Griesmann GE, Federspiel MJ, Rakela J, Borad MJ, Vile RG, Barber GN, Meier TR, Blanco MC, Carlson SK, Russell SJ, Peng KW. 2010. Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Hum. Gene Ther. 21:451-462. http://dx.doi.org/10.1089/hum.2009.111.
-
(2010)
Hum. Gene Ther.
, vol.21
, pp. 451-462
-
-
Jenks, N.1
Myers, R.2
Greiner, S.M.3
Thompson, J.4
Mader, E.K.5
Greenslade, A.6
Griesmann, G.E.7
Federspiel, M.J.8
Rakela, J.9
Borad, M.J.10
Vile, R.G.11
Barber, G.N.12
Meier, T.R.13
Blanco, M.C.14
Carlson, S.K.15
Russell, S.J.16
Peng, K.W.17
-
42
-
-
0029829073
-
Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies
-
Planz O, Seiler P, Hengartner H, Zinkernagel RM. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature 382:726-729. http://dx.doi.org/10.1038/382726a0.
-
(1996)
Nature
, vol.382
, pp. 726-729
-
-
Planz, O.1
Seiler, P.2
Hengartner, H.3
Zinkernagel, R.M.4
-
43
-
-
9644272538
-
Kinetics of protective antibodies are determined by the viral surface antigen
-
Pinschewer DD, Perez M, Jeetendra E, Bachi T, Horvath E, Hengartner H, Whitt MA, de la Torre JC, Zinkernagel RM. 2004. Kinetics of protective antibodies are determined by the viral surface antigen. J. Clin. Invest. 114:988-993. http://dx.doi.org/10.1172/JCI22374.
-
(2004)
J. Clin. Invest.
, vol.114
, pp. 988-993
-
-
Pinschewer, D.D.1
Perez, M.2
Jeetendra, E.3
Bachi, T.4
Horvath, E.5
Hengartner, H.6
Whitt, M.A.7
de la Torre, J.C.8
Zinkernagel, R.M.9
-
44
-
-
80053371681
-
Viruses-from pathogens to vaccine carriers
-
Small JC, Ertl HC. 2011. Viruses-from pathogens to vaccine carriers. Curr. Opin. Virol. 1:241-245. http://dx.doi.org/10.1016/j.coviro.2011.07.009.
-
(2011)
Curr. Opin. Virol.
, vol.1
, pp. 241-245
-
-
Small, J.C.1
Ertl, H.C.2
-
45
-
-
77949275849
-
Development of replicationdefective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
-
Flatz L, Hegazy AN, Bergthaler A, Verschoor A, Claus C, Fernandez M, Gattinoni L, Johnson S, Kreppel F, Kochanek S, Broek M, Radbruch A, Levy F, Lambert PH, Siegrist CA, Restifo NP, Lohning M, Ochsenbein AF, Nabel GJ, Pinschewer DD. 2010. Development of replicationdefective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat. Med. 16:339-345. http://dx.doi.org/10.1038/nm.2104.
-
(2010)
Nat. Med.
, vol.16
, pp. 339-345
-
-
Flatz, L.1
Hegazy, A.N.2
Bergthaler, A.3
Verschoor, A.4
Claus, C.5
Fernandez, M.6
Gattinoni, L.7
Johnson, S.8
Kreppel, F.9
Kochanek, S.10
Broek, M.11
Radbruch, A.12
Levy, F.13
Lambert, P.H.14
Siegrist, C.A.15
Restifo, N.P.16
Lohning, M.17
Ochsenbein, A.F.18
Nabel, G.J.19
Pinschewer, D.D.20
more..
-
46
-
-
84878826668
-
Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus
-
Halbherr SJ, Brostoff T, Tippenhauer M, Locher S, Berger Rentsch M, Zimmer G. 2013. Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus. PLoS One 8:e66059. http://dx.doi.org/10.1371/journal.pone.0066059.
-
(2013)
PLoS One
, vol.8
-
-
Halbherr, S.J.1
Brostoff, T.2
Tippenhauer, M.3
Locher, S.4
Berger Rentsch, M.5
Zimmer, G.6
-
47
-
-
33750000997
-
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
-
Xiang Z, Li Y, Cun A, Yang W, Ellenberg S, Switzer WM, Kalish ML, Ertl HC. 2006. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg. Infect. Dis. 12:1596-1599. http://dx.doi.org/10.3201/eid1210.060078.
-
(2006)
Emerg. Infect. Dis.
, vol.12
, pp. 1596-1599
-
-
Xiang, Z.1
Li, Y.2
Cun, A.3
Yang, W.4
Ellenberg, S.5
Switzer, W.M.6
Kalish, M.L.7
Ertl, H.C.8
-
48
-
-
0242500250
-
Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents
-
Lledo L, Gegundez MI, Saz JV, Bahamontes N, Beltran M. 2003. Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents. J. Med. Virol. 70:273-275. http://dx.doi.org/10.1002/jmv.10389.
-
(2003)
J. Med. Virol.
, vol.70
, pp. 273-275
-
-
Lledo, L.1
Gegundez, M.I.2
Saz, J.V.3
Bahamontes, N.4
Beltran, M.5
-
49
-
-
77957204031
-
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae
-
Chen H, Xiang ZQ, Li Y, Kurupati RK, Jia B, Bian A, Zhou DM, Hutnick N, Yuan S, Gray C, Serwanga J, Auma B, Kaleebu P, Zhou X, Betts MR, Ertl HC. 2010. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J. Virol. 84:10522-10532. http://dx.doi.org/10.1128/JVI.00450-10.
-
(2010)
J. Virol.
, vol.84
, pp. 10522-10532
-
-
Chen, H.1
Xiang, Z.Q.2
Li, Y.3
Kurupati, R.K.4
Jia, B.5
Bian, A.6
Zhou, D.M.7
Hutnick, N.8
Yuan, S.9
Gray, C.10
Serwanga, J.11
Auma, B.12
Kaleebu, P.13
Zhou, X.14
Betts, M.R.15
Ertl, H.C.16
-
50
-
-
56649105122
-
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
-
Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893. http://dx.doi.org/10.1016/S0140-6736(08) 61591-3.
-
(2008)
Lancet
, vol.372
, pp. 1881-1893
-
-
Buchbinder, S.P.1
Mehrotra, D.V.2
Duerr, A.3
Fitzgerald, D.W.4
Mogg, R.5
Li, D.6
Gilbert, P.B.7
Lama, J.R.8
Marmor, M.9
Del Rio, C.10
McElrath, M.J.11
Casimiro, D.R.12
Gottesdiener, K.M.13
Chodakewitz, J.A.14
Corey, L.15
Robertson, M.N.16
-
51
-
-
56649114351
-
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
-
McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-1905. http://dx.doi.org/10.1016/S0140-6736(08)61592-5.
-
(2008)
Lancet
, vol.372
, pp. 1894-1905
-
-
McElrath, M.J.1
De Rosa, S.C.2
Moodie, Z.3
Dubey, S.4
Kierstead, L.5
Janes, H.6
Defawe, O.D.7
Carter, D.K.8
Hural, J.9
Akondy, R.10
Buchbinder, S.P.11
Robertson, M.N.12
Mehrotra, D.V.13
Self, S.G.14
Corey, L.15
Shiver, J.W.16
Casimiro, D.R.17
-
52
-
-
0032755419
-
Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion
-
Svanholm C, Bandholtz L, Lobell A, Wigzell H. 1999. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. J. Immunol. Methods 228:121-130. http://dx.doi.org/10.1016/S0022-1759(99)00086-1.
-
(1999)
J. Immunol. Methods
, vol.228
, pp. 121-130
-
-
Svanholm, C.1
Bandholtz, L.2
Lobell, A.3
Wigzell, H.4
-
53
-
-
0031468120
-
Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscularDNAimmunization
-
Boyle JS, Koniaras C, Lew AM. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscularDNAimmunization. Int. Immunol. 9:1897-1906. http://dx.doi.org/10.1093/intimm/9.12.1897.
-
(1997)
Int. Immunol.
, vol.9
, pp. 1897-1906
-
-
Boyle, J.S.1
Koniaras, C.2
Lew, A.M.3
-
54
-
-
84861385675
-
The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate
-
Cobleigh MA, Bradfield C, Liu Y, Mehta A, Robek MD. 2012. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate. J. Virol. 86:4253-4261. http://dx.doi.org/10.1128/JVI.05991-11.
-
(2012)
J. Virol.
, vol.86
, pp. 4253-4261
-
-
Cobleigh, M.A.1
Bradfield, C.2
Liu, Y.3
Mehta, A.4
Robek, M.D.5
-
55
-
-
33745770012
-
Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha
-
Publicover J, Ramsburg E, Robek M, Rose JK. 2006. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. J. Virol. 80:7028-7036. http://dx.doi.org/10.1128/JVI.00478-06.
-
(2006)
J. Virol.
, vol.80
, pp. 7028-7036
-
-
Publicover, J.1
Ramsburg, E.2
Robek, M.3
Rose, J.K.4
|